Cyclizine (Emitex, Valoid As, Valoid Children's, Valoid, Valoid Paediatric, Triazine, Norizine, Triazine Paediatric)
Cyclizine
Pharmacare limited û woodmead
Registration
- Applicant
- Pharmacare limited û woodmead
- Registrations
- 11
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Emitex tablets EACH TABLET CONTAINS CYCLIZINE HYDROCHLORIDE 50 mg | Tablets | 28043528/5.7.2/0435 | Registered | Not determined | None |
| Emitex syrup EACH 5 ml CONTAINS CYCLIZINE HYDROCHLORIDE 12,5 mg | Syrup | 28043628/5.7/0436 | Cancelled | Not determined | None |
| Valoid as EACH SUPPOSITORY CONTAINS CYCLIZINE HYDROCHLORIDE 100,0 mg | Not listed | C0975C/5.7.2/975 | Registered | Not determined | None |
| Valoid children's suppositories EACH SUPPOSITORY CONTAINS CYCLIZINE HYDROCHLORIDE 50,0 mg | Suppositories | C0977C/5.7.2/977 | Registered | Not determined | None |
| Valoid EACH TABLET CONTAINS CYCLIZINE HYDROCHLORIDE 50 mg | Not listed | C0978C/5.7.2/978 | Registered | Not determined | None |
| Valoid paediatric syrup EACH 5,0 ml SYRUP CONTAINS CYCLIZINE HYDROCHLORIDE 12,5 mg | Syrup | D0097D/5.7/97 | Registered | Not determined | None |
| Triazine 50 MG suppositories EACH SUPPOSITORY CONTAINS CYCLIZINE HYDROCHLORIDE 50 mg | 50 mgSuppositories | M0160M/5.7.2/160 | Cancelled | Not determined | None |
| Triazine 100 MG suppositories EACH SUPPOSITORY CONTAINS CYCLIZINE HYDROCHLORIDE 100 mg | 100 mgSuppositories | M0161M/5.7.2/161 | Cancelled | Not determined | None |
| Triazine tablets EACH TABLET CONTAINS CYCLIZINE HYDROCHLORIDE 50 mg | Tablets | N0168N/5.7.2/168 | Registered | Not determined | None |
| Norizine tablets EACH TABLET CONTAINS CYCLIZINE HYDROCHLORIDE 50 mg | Tablets | X0200X/5.7/200 | Cancelled | Not determined | None |
| Triazine paediatric syrup EACH 5 ml SYRUP CONTAINS CYCLIZINE HYDROCHLORIDE 12,5 mg | Syrup | X0382X/5.7/382 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S2: Cyclizine
Consolidated Schedules 06 July 2026, line 1785
2 of 3 approved products with this ingredient carry S6 on their leaflet.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.